Adults' Acceptance of COVID-19 Vaccine for Children in Selected Lower- and Middle-Income Countries.

Africa Bangladesh Brazil COVID-19 vaccination Malaysia Thailand caretaker children lower- and middle-income countries parents

Journal

Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355

Informations de publication

Date de publication:
22 Dec 2021
Historique:
received: 05 11 2021
revised: 18 12 2021
accepted: 20 12 2021
entrez: 22 1 2022
pubmed: 23 1 2022
medline: 23 1 2022
Statut: epublish

Résumé

Since emergency approval of COVID-19 vaccines for children aged between 12 and 15 years old was recently obtained in the United States and Europe, we aimed to assess the willingness to vaccinate children with a COVID-19 vaccine in lower- and middle-income countries (LMICs). Therefore, we launched an online cross-sectional survey in several LMICs. Questions relating to socio-demographic information, knowledge of COVID-19, level of fear/worry of being infected with COVID-19, and willingness to vaccinate children with the COVID-19 vaccine at 50%, 75% and 95% effectiveness levels, were asked. Of the 6571 participants (mean age = 39 ± 14 years), 64.0%, 72.6%, and 92.9% were willing to vaccinate children at 50%, 75%, and 95% effectiveness levels, respectively. Respondents who were undergraduates, who were more worried/fearful about COVID-19, had higher knowledge scores regarding COVID-19, and a higher belief that COVID-19 vaccination is important to protect others, were more willing to accept COVID-19 vaccination of children. COVID-19 vaccination of children will limit the spread of the virus, especially in schools; it may decrease the need for school closures which has a negative effect on child development. Findings from this study are useful for health promotion strategies during COVID-19 vaccination implementation among children in LMICs.

Identifiants

pubmed: 35062672
pii: vaccines10010011
doi: 10.3390/vaccines10010011
pmc: PMC8778348
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : VLIRUOS (Flemish Interuniversity Council for University Development Cooperation)

Références

Health Place. 2021 Jan;67:102460
pubmed: 33418438
JMIR Pediatr Parent. 2020 Dec 30;3(2):e24827
pubmed: 33326406
EClinicalMedicine. 2020 Sep;26:100495
pubmed: 32838242
Vaccine. 2018 Nov 29;36(50):7666-7673
pubmed: 30391054
Eur J Public Health. 2010 Oct;20(5):490-4
pubmed: 20444821
Vaccine. 2017 Sep 5;35(37):4840-4850
pubmed: 28760616
N Engl J Med. 2022 Jan 6;386(1):35-46
pubmed: 34752019
Front Psychol. 2020 Sep 30;11:551004
pubmed: 33117223
Science. 2021 Nov 19;374(6570):913
pubmed: 34793207
Vaccine. 2021 Mar 12;39(11):1556-1564
pubmed: 33618947
Behav Res Methods. 2009 Nov;41(4):1149-60
pubmed: 19897823
Vaccine. 2011 Sep 2;29(38):6472-84
pubmed: 21756960
JAMA Pediatr. 2013 Mar 1;167(3):274-81
pubmed: 23338829
BMC Public Health. 2010 Oct 10;10:596
pubmed: 20932342
Lancet. 2020 Aug 15;396(10249):467-478
pubmed: 32702298
Hum Vaccin Immunother. 2020 Sep 1;16(9):2204-2214
pubmed: 32730103
Pediatrics. 2021 Oct;148(4):
pubmed: 34344800
Hum Vaccin Immunother. 2021 Jul 6;:1-6
pubmed: 34227914
Lancet Infect Dis. 2021 Dec;21(12):1614-1615
pubmed: 34197765
Nat Med. 2021 Feb;27(2):225-228
pubmed: 33082575
Lancet. 2020 May 9;395(10235):1461
pubmed: 32386576
Pediatr Infect Dis J. 2021 Apr 1;40(4):e134-e136
pubmed: 33410650
Pers Individ Dif. 2021 Apr;172:110590
pubmed: 33518869
BMJ Glob Health. 2020 Oct;5(10):
pubmed: 33097547
Vaccines (Basel). 2021 Oct 25;9(11):
pubmed: 34835174
Vaccine. 2020 Nov 10;38(48):7668-7673
pubmed: 33071002
Lancet. 2020 Aug 15;396(10249):479-488
pubmed: 32702299
Vaccines (Basel). 2021 Feb 05;9(2):
pubmed: 33562619
J Glob Health. 2021 Nov 20;11:05027
pubmed: 34912550
Child Care Health Dev. 2006 Jul;32(4):415-21
pubmed: 16784497
J Med Virol. 2021 Jul;93(7):4049-4053
pubmed: 33666240
Eur J Pediatr. 2011 Sep;170(9):1165-72
pubmed: 21347848
Pediatrics. 2006 Feb;117(2):e268-77
pubmed: 16452334
Vaccines (Basel). 2021 Sep 30;9(10):
pubmed: 34696223
Int J Environ Res Public Health. 2021 Sep 04;18(17):
pubmed: 34501932
Arch Dis Child. 2020 Dec 1;:
pubmed: 33262177
Vaccines (Basel). 2021 May 17;9(5):
pubmed: 34067682
Vaccine. 2011 Mar 16;29(13):2421-8
pubmed: 21277402
Lancet. 2020 Mar 14;395(10227):912-920
pubmed: 32112714
Vaccines (Basel). 2021 Jun 10;9(6):
pubmed: 34200835
Health Promot J Austr. 2019 Apr;30(2):143-152
pubmed: 30091836
Hum Vaccin Immunother. 2021 Nov 19;:1-7
pubmed: 34797754
Hum Vaccin Immunother. 2013 Aug;9(8):1755-62
pubmed: 23744504
J Rural Health. 2020 Sep;36(4):591-601
pubmed: 32602983
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
Vaccine. 2020 Nov 17;38(49):7789-7798
pubmed: 33109389

Auteurs

Suzanna Awang Bono (SA)

School of Social Science, Universiti Sains Malaysia, Gelugor 11800, Malaysia.

Ching Sin Siau (CS)

Centre for Community Health Studies (ReaCH), Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Kuala Lumpur 50300, Malaysia.

Won Sun Chen (WS)

Department of Health Science and Biostatistics, Faculty of Health, Arts and Design, Swinburne University of Technology, Hawthorn, VIC 3122, Australia.

Wah Yun Low (WY)

Faculty of Medicine, Universiti Malaya, Kuala Lumpur 50603, Malaysia.
Asia Europe Institute, Universiti Malaya, Kuala Lumpur 50603, Malaysia.

Edlaine Faria de Moura Villela (E)

Disease Control Coordination, Sao Paulo State Health Department, São Paulo 01246-000, Brazil.
Institute of Tropical Pathology and Public Health, Federal University of Goiás, Goiania 74690-900, Brazil.

Supa Pengpid (S)

ASEAN Institute for Health Development, Mahidol University, Nakhon Pathom 73170, Thailand.

M Tasdik Hasan (MT)

Jeeon Bangladesh Ltd., Dhaka 1207, Bangladesh.
Department of Primary Care & Mental Health, University of Liverpool, Liverpool L69 3BX, UK.

Philippe Sessou (P)

Research Unit on Communicable Diseases, Polytechnic School of Abomey-Calavi, University of Abomey-Calavi, Cotonou 01 BP 526, Benin.

John D Ditekemena (JD)

Kinshasa School of Public Health, University of Kinshasa, Kinshasa 7948, Democratic Republic of the Congo.

Bob Omoda Amodan (BO)

Uganda Public Health Fellowship Program, Loudel Towers, Level 4, Kampala 7272, Uganda.

Mina C Hosseinipour (MC)

School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
University of North Carolina Malawi, Lilongwe 999119, Malawi.

Housseini Dolo (H)

International Center of Excellence in Research, Faculty of Medicine and Odonto Stomatology, University of Sciences, Techniques and Technology of Bamako, Bamako BP 1805, Mali.

Joseph Nelson Siewe Fodjo (JN)

Global Health Institute, University of Antwerp, 2000 Antwerp, Belgium.
Brain Research Africa Initiative (BRAIN), Yaounde P.O. Box 25625, Cameroon.

Robert Colebunders (R)

Global Health Institute, University of Antwerp, 2000 Antwerp, Belgium.

Classifications MeSH